TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

28.10$ -2.5% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PBLS
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – +205.9%
– – – +238.9%
– – – +230.4%
– – – +240.6%
– – – -8.9%
– – – +15.9%
– – – -19.9%
– – – +23.2%
– – – +329.0%
– – – –
– +0.1% +1.5% +1,310.1%

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?